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registered at set time points. All procedures were digitally 
recorded, and the target to background ratio (TBR) was 
determined to assess the fluorescence signal.
Results With all three fluorescent dyes, the cystic artery 
was directly visualised. For the visualisation of the cystic 
duct, 15, 34 and 30 min were needed using  IRDye® 800BK, 
 IRDye® 800NOS and  IRDye® 800CW, respectively. The 
maximum TBR of the cystic duct was the highest with 
 IRDye® 800NOS (4.20) after 36 min, compared to 2.45 for 
 IRDye® 800BK and 2.15 for  IRDye® 800CW, both after 
45 min. There were no adverse events.
Conclusion IRDye® 800BK and  IRDye® 800NOS seem 
to be good alternatives for  IRDye® 800CW for the visuali-
sation of the cystic duct and cystic artery in pigs.
Keywords Fluorescent dyes · Near-infrared 
fluorescence imaging · Biliary anatomy · Laparoscopic 
cholecystectomy · Fluorescent cholangiography
Laparoscopic cholecystectomy is standard care for sympto-
matic gallbladder stones or acute cholecystitis, and is one 
of the most commonly performed surgical procedures in the 
Western hemisphere. The reported incidence of bile duct 
injuries in laparoscopic surgery is 0.4–1.4% [1, 2]. Such 
injuries are associated with increased morbidity, reduced 
survival, impaired quality of life and have economic conse-
quences for society [2, 3]. Anatomical variations of the bil-
iary ducts or vascular system are not uncommon and repre-
sent operative challenges and looming sources for operative 
complications [3, 4]. Therefore, enhanced intraoperative 
visualisation of the biliary anatomy is needed to reduce the 
incidence of bile duct injuries.
Near-infrared fluorescence (NIRF) imaging is a promis-
ing technique for real-time delineation of the perioperative 
Abstract 
Background Imaging techniques that enhance visuali-
sation of the anatomy may help prevent bile duct injury. 
Near-Infrared Fluorescence Imaging is such a technique. 
Previous experiments with ICG have shown that illumina-
tion of the extra-hepatic bile ducts is feasible. Yet, there is 
room for improvement in the visualisation of the target as 
compared to the background. Experiments with  IRDye® 
800CW show promising results. However, this dye is too 
expensive for routine clinical use. The aim of this study is 
to test the first applicability of two newly developed pre-
clinical dyes regarding intraoperative imaging of the cystic 
duct and cystic artery, compared with  IRDye® 800CW.
Methods Laparoscopic cholecystectomy was performed 
in three pigs, using a laparoscopic fluorescence imag-
ing system. Each pig received 6 mg of one of the fluores-
cent dyes (1 mg/mL;  IRDye® 800CW,  IRDye® 800BK or 
 IRDye® 800NOS) by intravenous injection. Intraoperative 
recognition of the biliary system and cystic artery was 
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anatomy. Among other applications, it is used for visuali-
sation of the extra-hepatic bile ducts and the cystic artery 
in laparoscopic cholecystectomy, and visualisation of the 
ureter in colorectal, urological and gynaecological sur-
gery [5–7]. In the clinical setting, ICG is the dye used for 
bile duct imaging, with reasonable visualisation results 
that makes clinical use possible. Both the extra-hepatic 
bile ducts and the cystic artery can be identified [8]. Sub-
jectively however, imaging of the target is not optimal in 
all patients. Better contrast between target and background 
is expected to increase the usefulness of the technique. 
Adaptation in the equipment and its characteristics is one 
way to address this issue. Alteration in the dye or its use 
is another. One such alteration is the suggestion to inject 
the dye a day before surgery [9]. However, due to usually 
performed same-day admission, this is undesirable from a 
logistic standpoint. Applying another fluorescent dye is a 
further possibility.
IRDye® 800CW (LICOR Biotechnology, Lincoln, 
United States) is an experimental dye, which in combi-
nation with laparoscopic imaging allows intraoperative 
visualisation of crucial anatomical structures. In a previ-
ous animal experiment, performed by our group, this dye 
was compared to ICG for imaging of the extra-hepatic bile 
ducts and the cystic artery in the pig. The main results 
were an earlier visualisation of the cystic duct, when using 
 IRDye® CW-800 and a higher target-to-background ratio 
for the cystic artery [10]. This is in line with two other 
studies and makes this new dye promising for future clini-
cal use [10–12]. However, a major disadvantage of  IRDye® 
CW-800 is its cost, which is almost tenfold that of ICG. 
Therefore, more affordable alternatives are needed.
Recently, the manufacturer of  IRDye® 800CW devel-
oped two new preclinical dyes,  IRDye® 800BK and 
 IRDye® 800NOS, that can be produced at a cost that is 
comparable to commercially available ICG. In general, the 
three dyes have similar properties. Emission and absorption 
are at about the same wavelength as for ICG. The dyes dif-
fer in hydrophilic properties, with  IRDye® 800NOS being 
the least hydrophilic. This influences their excretion and 
their uptake in the liver and may make them more potent 
with regard to their imaging capabilities of the cystic duct. 
The aim of the present study was to evaluate the perfor-
mance of these dyes as compared to  IRDye® 800CW for 
NIRF laparoscopy of the extra-hepatic bile ducts and the 
cystic artery in pigs using a commercially available laparo-
scopic fluorescence imaging system.
Materials and methods
This study was conducted at the central animal facilities 
of Maastricht University (Maastricht, The Netherlands). 
Animals were used in compliance with the regulations of 
the Dutch legislation for animal research and following a 
protocol that was approved by the local animal ethics com-
mittee. A pig model was chosen because of its similarity 
with human hepatobiliary anatomy and because previously 
successful experiments have been conducted with NIRF 
imaging in pigs [10]. Three female Dutch landrace pigs, 
weighing 40 kg, were used for the current study. After sur-
gery, the pigs were sacrificed by the anaesthesiologist.
Laparoscopic fluorescence imaging system
A commercially available laparoscopic fluorescence imag-
ing system (Karl Storz GmbH & CO. KG, Tuttlingen, 
Germany) was used. The NIR light source D-Light P is a 
xenon-based system providing illumination light for fluo-
rescence applications in the near-infrared wavelength 
range. It enables the excitation of all presented dyes: 
IRDye 800CW (ʎEX/EM = 775/796  nm), IRDye 800BK 
(ʎEX/EM = 774/790  nm) and IRDye 800NOS (ʎEX/
EM = 767/786 nm). A foot pedal allows the surgeon to eas-
ily switch between the two imaging modalities. All proce-
dures were digitally recorded. For all three dyes, the same 
NIRF imaging settings were used.
Characteristics and preparation of near-infrared dyes
IRDye® 800CW is a tetrasulphonated heptamethine indo-
cyanine dye. Intravenous injection is rapidly cleared by the 
liver and excreted into bile. It is also cleared by the kid-
neys and excreted into urine. The peak absorption of this 
dye is 775 nm and peak excitation emission at 796 nm. The 
molecular weight is 1090.11 Da [13, 14].
IRDye® 800BK (LICOR Biotechnology, Lincoln, United 
States) is a newly developed dye, primarily developed for 
intraoperative visualisation of the ureters. This hydrophilic 
dye has a maximum absorption of 774 nm and a maximum 
emission of 790 nm. Because of its hydrophilic nature, it is 
primarily cleared by the kidneys. Nevertheless, being simi-
lar in structure as  IRDye® 800CW, some additional clear-
ance by the liver can be expected.
IRDye® 800NOS (LICOR Biotechnology, Lincoln, 
United States) is also a newly developed dye, less hydro-
philic, mainly developed for intraoperative visualisation of 
the biliary system. This dye is primarily cleared by the liver 
and has a maximum absorption of 767 nm and a maximum 
emission of 786 nm.
All three dyes were prepared following instructions of 
the manufacturer. They were diluted in a sterile phosphate-
buffered saline (PBS) solution to a concentration of 1 milli-
gram per millilitre. Six milligrams of each dye in this dilu-




Premedication consisted of intramuscular injection of azap-
erone 3 mg/kg, ketamine 10 mg/kg and atropine 0.05 mg/
kg. Anaesthesia was induced with intravenous thiopen-
tal 10-15mg/kg. After intubation, the pigs were main-
tained under anaesthesia with isoflurane and oxygen. Two 
expert endoscopic gastrointestinal surgeons (NB and LS) 
performed the operations and were assisted by residents 
experienced in the procedure. In each pig, a laparoscopic 
cholecystectomy was performed, according to the Dutch 
Guidelines and best practice for laparoscopic cholecystec-
tomy applying the Critical View of Safety technique [15, 
16]. One dye was tested per animal using a 6  mg dose 
(1 mg/mL). This was twice the dose proven sufficient in an 
earlier study [10]. The dose was chosen to obtain maximal 
visualisation since our hypothesis was that a higher dose of 
the dye would result in better biliary imaging. Fluorescence 
imaging was initiated immediately after dye injection and 
subsequently imaging was performed intermittently in fluo-
rescence mode and white light mode. Intra-operatively, the 
researcher systematically documented on a form whether 
the cystic duct or cystic artery could be identified, in either 
of the imaging modes. For agreement on the identification 
on the aforementioned structures, the attending surgeon 
was consulted. A structure was scored as ‘identified’ if 
its localisation was confirmed with great certainty by the 
experienced surgeon.
Postoperative quantitative fluorescence analysis
The video recordings of the procedures were assessed for 
the degree of fluorescence illumination using OSIRIX 
v7.0.1 Imaging software (Pixmeo, Geneva, Switzerland). 
With this software, the Target-to-Background Ratio (TBR) 
could be determined. The TBR was defined as the mean 
fluorescence intensity (FI in arbitrary units, A.U.) of three 
points of interest in the target (cystic artery or cystic duct), 
minus the mean fluorescence intensity of three points of 
interest in the background (liver hilum), divided by the 
mean fluorescence intensity of three points of interest in the 
background. In formula: TBR = (FI of target – FI of back-
ground)/ (FI background) [8, 10]. Areas with light scatter-
ing were avoided in these points of interest.
Results
In all experiments, the identification of the cystic duct and 
cystic artery with NIRF imaging was successfully con-
ducted. Results obtained during the operation are presented 
in the intraoperative registration form in Table 1.
In the first pig  (IRDye® 800BK), direct clear visualisa-
tion of the cystic artery was present after injecting the fluo-
rescent dye. Already after 15 min, the cystic duct showed 
NIRF signal. The second pig  (IRDye® 800NOS) showed 
immediate visualisation of the cystic artery after injection 
of the dye. However, due to a technical problem early in the 
procedure, this visualisation was not recorded, and there-
fore no TBR could be obtained from this fluorescent cystic 
artery. After 34  min, the cystic duct was clearly visible. 
However, manipulation of the gallbladder proved to be of 
influence on the visualisation of the cystic duct. Too much 
stretching of the fragile duct prohibited influx of fluores-
cent dye. This was corrected at 34 min. As in the first two 
pigs, the cystic artery was also clearly visible in the third 
pig receiving  IRDye® 800CW dye. After 30 min, the cystic 
duct could be identified in the fluorescence mode.
In all three pigs, apart from the cystic duct and cystic 
artery, other structures became visible. The bicornate 
uterus was subjectively the most fluorescent in the abdo-
men of all three pigs. Also, the ureters, small bowel and 
lymph nodes were visible in fluorescence mode in all three 
pigs.
Target-to-background ratio
Postoperatively, the video recordings were analysed by 
measuring the Target-to-Background Ratio (TBR). The 
TBR’s of cystic artery for  IRDye® 800BK and  IRDye® 
800CW were 6.78 and 7.54, respectively. The TBR of the 
cystic artery for  IRDye® 800NOS could not be measured 
because of a technical problem regarding the video record-
ing procedures early in the operation. The maximum meas-
ured TBRs from the three dyes for the cystic duct were 
2.45 (at 45 min), 4.20 (at 35 min) and 2.15 (at 45 min) for 
 IRDye® 800BK,  IRDye® 800NOS and  IRDye® 800CW, 
respectively. Images 1–3 show the cystic ducts during these 
maximum measured TBRs. All images were made in the 
same fluorescence settings of the Image1 SPIES system. 
Table 1  Intraoperative 






1 IRDye® 800BK Yes Yes 15 min
2 IRDye® 800NOS Yes Yes 34 min
3 IRDye® 800CW Yes Yes 30 min
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However, as can be seen in the images, with the  IRDye® 
800NOS, the laparoscope was at further distance from the 
cystic duct. The images with the maximum TBR for each 
dye are shown in Fig. 1,2 and 3.
Safety
In none of the pigs complications or adverse reactions were 
registered during surgery that could be attributed to one of 
the dyes. In particular, no alteration in heart rate and blood 
pressure of respiratory status was observed. Only a slightly 
and transient decrease in intraoperative monitoring of the 
Saturation of peripheral Oxygen  (SpO2) was observed dur-
ing the first minute after injection of the fluorescent dyes.
Discussion
In the present study, the use of two new preclinical dyes for 
NIRF imaging of the extrahepatic bile ducts with a com-
mercially available laparoscopic imaging system was inves-
tigated. The new dyes resemble the structure and spectral 
characteristics of the previously favourably tested  IRDye® 
800CW but are much less costly, now being in the range 
of commercially available ICG. Both features are essen-
tial for possible future clinical application. The aim of the 
experiments was to perform a first assessment of the NIRF 
properties of the new dyes and compare these to the per-
formance of  IRDye® 800CW. Eventually, these dyes could 
be an alternative to ICG, the only dye presently available 
for human use in NIRF imaging of the biliary system. This 
would be desirable, as with ICG, although NIRF visualisa-
tion of the bile ducts can be achieved, the observed con-
trast of target-to-background leaves room for improvement. 
Other advantages are a shorter period between injection of 
the dye and visualisation of the target structures and the 
fact that these new dyes contain no iodine, whereas some 
Fig. 1  Visualisation of the cystic duct, 45 min (time point of maxi-
mal signal) after injecting 6 mg of  IRDye® 800BK (1 mg/mL). Note 
the little white spots are caused by scattering, and do not represent the 
fluorescent signal
Fig. 2  Visualisation of the cystic duct (pointed by arrow), and the 
base of the gallbladder 35 min (time point of maximal signal) after 
injecting 6 mg of  IRDye® 800NOS (1 mg/mL)
Fig. 3  Visualisation of the cystic duct (pointed by arrow) and com-
mon bile duct, 45 min (time point of maximal signal) after injecting 
6 mg of  IRDye® 800CW (1 mg/mL). Note the white spots are caused 
by scattering, and do not represent the fluorescent signal
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of the commercially available ICG preparations do [17]. 
These new dyes are therefore also applicable in patients 
that are known with an iodine allergy or hypersensitivity. 
A final benefit could be that these dyes are not only exclu-
sively cleared by the liver, but also by the kidneys, a fact 
that is known from  IRDye® 800CW. This may make these 
dyes appropriate for ureter imaging.
All three dyes showed clear visualisation of the cystic 
artery directly after intravenous injection. Between 15 and 
35 min, with all three dyes, clear visualisation of the cystic 
duct was achieved. Both  IRDye® 800BK and  IRDye® 
800NOS caused a more prominent fluorescent signal than 
the earlier tested  IRDye® 800CW. The TBR of 2.15 found 
for  IRDye® 800CW in this study is comparable with that 
in an earlier study, where the TBR was 2.3 [10]. The signal 
from  IRDye® 800NOS was stronger than that from  IRDye® 
800BK. This was expected, as  IRDye® 800NOS is less 
hydrophilic and supposed to be excreted through the bile 
more exclusively than  IRDye® 800BK. In a previous study, 
the TBR’s of ICG and  IRDye® CW800 were comparable 
[10]. The present results suggest that the  IRDye® 800NOS 
might be more potent for bile duct imaging. This corre-
sponds to the subjective impression of the surgeons. Of 
course, these data have to be interpreted with caution and 
need confirmation. A possible limitation in the measure-
ment of the TBR in this study is the not uniformly defined 
distance between laparoscope and cystic duct at vary-
ing time points. As shown in Images 1–3, this distance is 
greater in the pig with  IRDye® 800NOS. A larger distance 
between the region of interest and the laparoscope may lead 
to a lower fluorescence intensity [18]. However, the TBR 
for  IRDye® 800NOS was the highest of all found TBRs.
There were no adverse reactions as a result of the admin-
istration of the dye. A very early and transient decrease in 
oxygen saturation was measured; this is a common phe-
nomenon with the use of intravenous fluorescent dyes 
[19–21]. The transient changing of the colour of the blood 
results in the oxygen measurements becoming falsely lower 
than the real value.
During the experiment, it was observed that the three 
dyes were all cleared by both the liver (and excreted into 
bile) and the kidneys (and excreted into urine). Therefore, 
all three dyes might be eligible for both imaging of the bil-
iary anatomy and of the ureters, although, as previously 
mentioned,  IRDye® 800NOS is more exclusively excreted 
in bile and  IRDye® 800BK more in urine. This was con-
firmed by the higher TBR in the bile duct for  IRDye® 
800NOS in this experiment. The exact behaviour of these 
dyes needs further study for both biliary and urinary imag-
ing. Because of the uncertainty on the amount of the dyes 
that is lost in urine, the given dose was set twice as high 
as in a previous experiment with successful bile duct 
imaging with  IRDye® 800CW [10]. The TBR of  IRDye® 
800CW in the present study was comparable to the previ-
ous observation which might indicate that the double dose 
is of no influence when using  IRDye® 800CW. In the pre-
sent study,  IRDye® 800CW took longer to become visible 
than reported in the study by Schols et al. 2014, where the 
cystic duct was distinguishable after 11 min [10]. Tanaka 
et  al. 2014 measured fluorescence in the cystic duct after 
around 20 min, which is comparable to the current results 
[11]. The different doses used may have had an influence 
on the time until the appearance of fluorescence. Neither 
can it be ruled out that another dose than the one chosen 
gives superior imaging. Further experiments are needed to 
determine optimal dosing and timing that are influenced by 
the pharmacokinetic properties of the dyes.
This study has two other limitations. First, because of 
the limited series of experiments, the results have to be 
interpreted with caution. Since only three pigs were used, 
each dye was tested only in one pig. This resulted in the 
fact that the failure to start video recordings early in the 
second pig, in which  IRDye® 800NOS was tested, could 
not be corrected in a subsequent experiment. Measure-
ment of the visualisation of the cystic artery with TBR was 
therefore not possible in this pig. Another limitation is the 
fact that we observed influence of the manipulation with 
the gallbladder and cystic duct on flow of the fluorescent 
dye in the bile through the cystic duct in the second pig. It 
cannot be ruled out that earlier imaging could have been 
obtained with adaptation of manipulation. This may have 
influenced the bile flow and the detailed time measure-
ments in the other pigs. A drawback of the procedures was 
the necessity to switch intermittently between NIRF- and 
white light imaging of the biliary system. This is inherent 
to the equipment used. Although likely that simultaneous 
white- and fluorescent light imaging is more practical, the 
surgeons did not experience this as hindering, and measure-
ments could be performed at a sufficient number of time 
points to perform relevant observations.
This study focusses fully on the evaluation of new dyes 
to optimise NIRF imaging. Another way to improve NIRF 
imaging is adaptation of the equipment and its properties. 
Such approach is also very important, but outside the scope 
of the present experiments.
Conclusion
The present study shows promising results on two new 
and affordable dyes for NIRF imaging:  IRDye® 800BK 
and  IRDye® 800NOS with respect to near-infrared fluores-
cence imaging of the cystic duct and cystic artery. At this 
moment, these dyes are not yet FDA approved, which also 
still is the case for  IRDye® 800CW, and are therefore not 
applicable for human clinical practice yet. The new dyes 
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seem to be good alternatives for  IRDye® 800CW in the 
visualisation of the cystic duct and cystic artery in pigs. In 
order to be an alternative for the only dye that is at pre-
sent available for human use, ICG, further studies and FDA 
approval are needed.
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